Tag Archives: diabetes

Market Recap April Fools, Stock Picks for 3-2

Today was a great day but before we begin with our usual post I would like to get a point across to our fan base/ followers. Anyone who has made money from our advice and stock picks we do not … Continue reading

Rate this:

Posted in stock market | Tagged , , , , , , , | Leave a comment

MannKind Corp. (MNKD) receives an “okay” from the FDA

After-hours today MannKind Corp. got a verbal “yes” from the FDA on their inhaled diabetes treatment, Afrezza. FDA approved advisors voted positively for the MNKD drug. Afrezza received a 13 to 1 vote for the drug to be used to … Continue reading

Rate this:

Posted in stock market, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

Afrezza’s Outlook on April 1st

As you all may already know shares of MNKD were halted ahead of the AdCom. At Hereitfirst we have been monitoring for the last 4 months. We have come to believe that MNKD will almost certainly be approved for Type … Continue reading

Rate this:

Posted in stock market | Tagged , , , , , , , , , , , | 6 Comments

Post Briefing Analysis On MNKD

MNKD had a roller coaster day as they stormed right out of the gate with highs of 5.75 ( Up 9% ) before closing at 4.83 ( down 7%). This could be attributed to the fact that good news came … Continue reading

Rate this:

Posted in stock market | Tagged , , , , , , , , , , , | 7 Comments